136
Participants
Start Date
March 2, 2018
Primary Completion Date
August 31, 2021
Study Completion Date
December 31, 2025
Niraparib 200 mg
Participants will receive niraparib 200 mg orally.
Cetrelimab 240 mg
Participants will receive cetrelimab 240 mg IV every 2 weeks.
Cetrelimab 480 mg
Participants will receive cetrelimab 480 mg IV every 4 weeks.
Abiraterone acetate 1000 mg
Participants will receive AA 1000 mg orally.
Prednisone 5 mg
Participants will receive prednisone 5 mg orally.
ULB Hôpital Erasme, Brussels
ZNA Middelheim, Antwerp
Hospital Vall D'Hebron, Barcelona
Az Groeninge, Kortrijk
Universitair Ziekenhuis Gent, Ghent
OLV Ziekenhuis Aalst, Aalst
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center, Harrison
New York Oncology Hematology, Albany
University of Pittsburgh Medical Center (UPMC), Pittsburgh
Thomas Jefferson University, Philadelphia
ASST Grande Ospedale Metropolitano Niguarda, Milan
Chesapeake Urology Research Associates, Towson
Urology of Virginia, PLCC, Virginia Beach
Hosp. Univ. de La Princesa, Madrid
Hosp Univ Fund Jimenez Diaz, Madrid
Hosp Univ Hm Sanchinarro, Madrid
Hosp Virgen de La Victoria, Málaga
MUSC-Hollings Cancer Center, Charleston
Carolina Urologic Research Center, Myrtle Beach
Rambam Medical Center, Haifa
Mayo Clinic - Division Of Hematology/oncology, Jacksonville
Urology Associates, Nashville
First Urology, PSC, Jeffersonville
Michigan Institute of Urology, Troy
Rabin Medical Center, Petah Tikva
Azienda Ospedaliera Universitaria Careggi di Firenze, Florence
Sheba Medical Center Tel Hashomer, Ramat Gan
Asaf Harofe Medical Center, Beer Yaakov
UOC Oncologia Ospedale Provinciale di Macerata, Macerata
Azienda Ospedaliera ''Vito Fazzi'', Lecce
Houston Metro Urology, Houston
The University of Texas MD Anderson Cancer Center, Houston
IRCCS-Fondazione Pascale, Napoli
The Urology Center of Colorado, Denver
Utah Cancer Specialists, Salt Lake City
Soroka Hospital, Beersheba
Urological Associates of Southern Arizona, P.C., Tucson
University of Wisconsin Carbone Cancer Center, Madison
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liège
Southern Alberta Institute of Urology / Prostate Cancer Centre, Calgary
British Columbia Cancer Agency, Vancouver
Princess Margaret Cancer Centre University Health Network, Toronto
Centre de Recherche du CHUM, Montreal
Hosp. de La Santa Creu I Sant Pau, Barcelona
Royal United Hospital, Bath
University College London Hospitals, London
Southampton General Hospital, Southampton
The Royal Marsden NHS Trust Sutton, Sutton
Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital, Truro
Janssen Research & Development, LLC
INDUSTRY